Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABRAFENIB Cause Systemic inflammatory response syndrome? 23 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Systemic inflammatory response syndrome have been filed in association with DABRAFENIB (Tafinlar). This represents 0.1% of all adverse event reports for DABRAFENIB.

23
Reports of Systemic inflammatory response syndrome with DABRAFENIB
0.1%
of all DABRAFENIB reports
1
Deaths
19
Hospitalizations

How Dangerous Is Systemic inflammatory response syndrome From DABRAFENIB?

Of the 23 reports, 1 (4.3%) resulted in death, 19 (82.6%) required hospitalization, and 3 (13.0%) were considered life-threatening.

Is Systemic inflammatory response syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does DABRAFENIB Cause?

Pyrexia (3,788) Death (2,740) Malignant neoplasm progression (1,667) Fatigue (1,328) Nausea (1,300) Chills (1,235) Rash (1,078) Vomiting (907) Diarrhoea (901) Headache (697)

What Other Drugs Cause Systemic inflammatory response syndrome?

DOXORUBICIN (161) METHOTREXATE (158) CYCLOPHOSPHAMIDE (153) CYTARABINE (153) METHYLPREDNISOLONE (117) ADALIMUMAB (107) RITUXIMAB (106) PREDNISOLONE (99) VINCRISTINE (97) MYCOPHENOLATE MOFETIL (95)

Which DABRAFENIB Alternatives Have Lower Systemic inflammatory response syndrome Risk?

DABRAFENIB vs DABRAFENIB\TRAMETINIB DABRAFENIB vs DACARBAZINE DABRAFENIB vs DACLATASVIR DABRAFENIB vs DACLIZUMAB DABRAFENIB vs DACOMITINIB

Related Pages

DABRAFENIB Full Profile All Systemic inflammatory response syndrome Reports All Drugs Causing Systemic inflammatory response syndrome DABRAFENIB Demographics